Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adverse Prognosis
20%
Angiotensin-converting Enzyme Inhibitor (ACEi)
20%
Antihypertensive Drug Class
20%
Antihypertensive Drugs
20%
Beta-blockers
60%
Blood Pressure
100%
Blood Pressure Values
60%
Cardiovascular Comorbidities
20%
Comorbidity
20%
Comorbidity Adjustment
40%
Dialysis
60%
Diastolic Blood Pressure
20%
Diastolic Pressure
20%
Generated Samples
20%
Hazard Ratio
20%
Hemodialysis
20%
Hemodialysis Patients
100%
High Pulse Pressure
60%
Interdialytic Weight Gain
80%
Long-term Mortality
100%
Long-term Prognosis
20%
Low Mortality
20%
Old Age
20%
Post-dialysis
100%
Pre-dialysis
80%
Prognostic Discrimination
20%
Short-term Survival
20%
Systolic Blood Pressure
20%
Systolic Pressure
20%
United States
100%
United States Renal Data System (USRDS)
100%
Vital Status
20%
Weight numbers
20%
Medicine and Dentistry
ACE Inhibitor
25%
Antihypertensive
25%
Antihypertensive Agent
75%
Beta Adrenergic Receptor Blocking Agent
75%
Blood Pressure
100%
Cardiovascular System
25%
Comorbidity
100%
Diastolic Blood Pressure
50%
Hazard Ratio
25%
Hemodialysis
100%
Morbidity
25%
Pulse Pressure
75%
Systolic Blood Pressure
50%
Nursing and Health Professions
Antihypertensive Agent
75%
Beta Adrenergic Receptor Blocking Agent
75%
Blood Pressure
100%
Cardiovascular System
25%
Comorbidity
100%
Dialysis Machine
25%
Diastolic Blood Pressure
50%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Hazard Ratio
25%
Hemodialysis
100%
Morbidity
25%
Pulse Pressure
75%
Systolic Blood Pressure
50%
Psychology
Blood Pressure
100%
Comorbidity
80%
Hazard Ratio
20%
Systolic Blood Pressure
20%
United States of America
100%
Weight Gain
80%
Chemistry
Angiotensin-Converting Enzyme Inhibitor
20%
Antihypertensive
40%
Antihypertensive Agent
60%
Blood Pressure
100%
Protective
20%
Weight Gain
80%